Clinical Practice Guidelines for Hypothyroidism in Adults ...

PRACTICE GUIDELINES FOR HYPOTHYROIDISM IN ADULTS 1235299. Strisower EH, Strisower B 1964 The separate hypolipoproteinemiceffects of dextrothyroxine and ethylchlorophenoxyisobutyrate. J Clin Endocrinol Metab24:139–144.300. Ladenson PW, Kristensen JD, Ridgway EC, OlssonAG, Carlsson B, Klein I, Baxter JD, Angelin B 2010Use of the thyroid hormone analogue eprotirome instatin-treated dyslipidemia. N Engl J Med 362:906–916.301. Berkenstam A, Kristensen J, Mellstrom K, CarlssonB, Malm J, Rehnmark S, Garg N, Andersson CM,Rudling M, Sjoberg F, Angelin B, Baxter JD 2008 Thethyroid hormone mimetic compound KB2115 lowersplasma LDL cholesterol and stimulates bile acidsynthesis without cardiac effects in humans. ProcNatl Acad Sci USA 105:663–667.302. Ladenson PW, McCarren M, Morkin E, EdsonRG, Shih MC, Warren SR, Barnhill JG, ChurbyL, Thai H, O’Brien T, Anand I, Warner A, HattlerB, Dunlap M, Erikson J, Goldman S 2010 Effectsof the thyromimetic agent diiodothyropropionicacid on body weight, body mass index, and serumlipoproteins: a pilot prospective, randomized, controlledstudy. J Clin Endocrinol Metab 95:1349–1354.303. Abalovich M, Amino N, Barbour LA, Cobin RH, DeGroot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A2007 Management of thyroid dysfunction duringpregnancy and postpartum: an Endocrine SocietyClinical Practice Guideline. J Clin Endocrinol Metab92:S1–47.304. Gharib HC, Cobin RH, Dickey RA 1999 Subclinicalhypothyroidism during pregnancy: position statementfrom the American Association of ClinicalEndocrinologists. Endocr Pract 5:367–368.305. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA,McDermott MT 2005 Subclinical thyroid dysfunc-EL3EL1EL2EL1EL4EL4EL4tion: a joint statement on management from theAmerican Association of Clinical Endocrinologists,the American Thyroid Association, and the EndocrineSociety. J Clin Endocrinol Metab 90:581–585;discussion 586–587.306. Vaidya B, Anthony S, Bilous M, Shields B, Drury J,Hutchison S, Bilous R 2007 Detection of thyroiddysfunction in early pregnancy: universal screeningor targeted high-risk case finding? J Clin EndocrinolMetab 92:203–207.307. Negro R, Schwartz A, Gismondi R, Tinelli A, MangieriT, Stagnaro-Green A 2010 Universal screeningversus case finding for detection and treatment ofthyroid hormonal dysfunction during pregnancy. JClin Endocrinol Metab 95:1699–1707.308. Thung SF, Funai EF, Grobman WA 2009 The costeffectivenessof universal screening in pregnancy forsubclinical hypothyroidism. Am J Obstet Gynecol200:267 e261–267.309. Weiss RE, Refetoff S 2010 Thyroid function testing.In: Jameson JL, DeGroot LJ (eds) Endocrinology:Adult and Pediatric, 6th edition. Saunders Elsevier,Philadelphia, PA, pp 1444–1492.310. Barbesino G 2010 Drugs affecting thyroid function.Thyroid 20:763–770.311. Hamnvik OP, Larsen PR, Marqusee E 2011 Thyroiddysfunction from antineoplastic agents. J Natl CancerInst 103:1572–1578.EL2EL1EL4EL4EL4EL4Address correspondence to:Jeffrey R. Garber, M.D.Endocrinology DivisionHarvard Vanguard Medical Associates133 Brookline AvenueBoston, MA 02215E-mail: jgarber@bidmc.harvard.edu